Acerus to Report Third Quarter 2019 Financial Results and Host Investor Call
TORONTO--(BUSINESS WIRE)--Nov 6, 2019--
Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB :ASPCF) will announce its third quarter 2019 financial and operating results on Thursday, November 14, 2019 before the market opens. The company will also host a conference call on Thursday, November 14, 2019 at 8:30 a.m. Eastern Time.
To access the call live, please dial 416-340-2219 or 1-800-478-9326. Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays. A replay of the conference call will be available until 11:59 p.m. Eastern Time on Thursday, November 21, 2019 by dialing 905-694-9451 or 1-800-408-3053, using access code: 2401991#.
Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of innovative, branded products that improve patient experience, with a primary focus in the field of men’s health. The Company commercializes its products via its own salesforce in Canada, and through a global network of licensed distributors in the U.S. and other territories.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191106005077/en/
CONTACT: Acerus Pharmaceuticals Corporation
Chief Financial Officer
KEYWORD: NORTH AMERICA CANADA
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH
SOURCE: Acerus Pharmaceuticals Corporation
Copyright Business Wire 2019.
PUB: 11/06/2019 07:30 AM/DISC: 11/06/2019 07:30 AM